MGRX

0.23% 0.0012

Dopo l'orario di chiusura: .51 -0.0244 -4.57%

Mangoceuticals Inc (MGRX)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Mangoceuticals Inc Stock (MGRX) Company Profile

Mangoceuticals Inc

Healthcare (1080)

(833) 626-4679

15110 DALLAS PKWY, SUITE 600, DALLAS

Prossima data di guadagno

Ultimi documenti SEC

MGRX's Discussions on Twitter

Compare MGRX vs VEEV, BTSG, TEM, HQY, TXG

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
MGRX Mangoceuticals Inc	0.5344	9.15M	414.60K	-19.21M	-4.89M	-1.6207
VEEV Veeva Systems Inc	243.75	39.23B	3.32B	941.65M	1.64B	5.6161
BTSG Brightspring Health Services Inc	61.71	11.81B	13.65B	169.86M	412.12M	1.0758
TEM Tempus Ai Inc	52.10	9.85B	1.36B	-302.91M	-219.93M	-1.7182
HQY Healthequity Inc	104.73	8.82B	1.34B	230.70M	440.96M	2.6695
TXG 10 X Genomics Inc	56.09	7.52B	638.78M	-22.66M	122.18M	-0.1744

Mangoceuticals Inc Borsa (MGRX) Ultime notizie

Mangoceuticals Inc Azioni (MGRX) Dati Finanziari

Mangoceuticals Inc (MGRX)

Mangoceuticals Inc Stock (MGRX) Company Profile

Compare MGRX vs VEEV, BTSG, TEM, HQY, TXG

Mangoceuticals Inc Borsa (MGRX) Ultime notizie

MANGOCEUTICALS, INC. Q2 2026: Revenue $68.76K, EPS $(0.09) — 10-Q Summary - TradingView

Mangoceuticals (MGRX) Q2 2026 loss shrinks while cash and revenue fall - Stock Titan

Mangoceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

12 Consumer Staples Stocks Moving In Thursday's After-Market Session - Benzinga

Nuclea’s planned Moltex deal could add 80 nuclear patents - Stock Titan

Why is Mangoceuticals stock surging today? - Investing.com India

On Thursday, there are stocks with unusual volume. Let's take a look. - ChartMill

Why is Mangoceuticals stock surging today? By Investing.com - Investing.com South Africa

Mangoceuticals’ Merger Partner, Nuclea Energy Inc., Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure - The Manila Times

Mangoceuticals’ Merger Partner, Nuclea Energy Inc., Signs - GlobeNewswire

Mangoceuticals (MGRX) merger partner Nuclea inks Utah nuclear test reactor MOU - Stock Titan

Mangoceuticals (MGRX) Stock Jumps Over 49% After Hours: Here's Why - Benzinga

Mangoceuticals merger partner Nuclea signs MOU with New Mining on modular reactor power for data centers - Bitget

Mangoceuticals Wins Nasdaq Extension Amid Nuclea Deal Progress - The Globe and Mail

Wondering what's happening in today's after-hours session? - ChartMill

Mangoceuticals’ Merger Partner, Nuclea Energy (“Nuclea”), Executes MOU with Utah Office of Energy Development - Yahoo Finance

Mangoceuticals (NASDAQ: MGRX) wins more time on Nasdaq rules, advances Nuclea deal - Stock Titan

Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination - The Manila Times

Mangoceuticals Inc. (MGRX) Slides 15% to $0.45 as Selling Pressure IntensifiesSmart Money Flow Stocks - dars.gov.et

$Mangoceuticals (MGRX.US)$ - moomoo.com

Mangoceuticals, Inc. Common Stock (NASDAQ: MGRX) Stock Price, News & Analysis - Kalkine

Microcaps MGRX, PRSO, IGC, KUST In the News to Watch - openPR.com

That’s quite fortunate! - Moomoo

$Mangoceuticals (MGRX.US)$ wow finally CB ⬆️ [Grin][Drool][Cool Guy][Angry][Tongue] - moomoo.com

$Mangoceuticals (MGRX.US)$ sold a tad early. but definitely looking for another entry! - Moomoo

Mangoceuticals (NASDAQ:MGRX) Shares Surge Almost Threefold Following Nuclea Agreement; Existing Shareholders Retain 4% - TechStock²

Form 4 Mangoceuticals Inc For: 30 July By Investing.com - Investing.com Canada

Nuclea Energy to go public via merger with Mangoceuticals By Investing.com - Investing.com Nigeria

Nuclea Energy Enters Definitive Business Combination Agreement with Mangoceuticals, Establishing a Path to a Nasdaq Public Listing to Advance the Morpheus Microreactor - TMX Newsfile

Nuclea Energy Inc: Nuclea Energy Enters Definitive Business Combination Agreement with Mangoceuticals, Establishing a Path to a Nasdaq Public Listing to Advance the Morpheus Microreactor - FinanzNachrichten.de

Mangoceuticals agrees to merge with nuclear microreactor developer - Investing.com Nigeria

Mangoceuticals agrees to merge with nuclear microreactor developer By Investing.com - Investing.com Canada

Jacob D. Cohen to Leave CEO Role at Mangoceuticals, Becomes President in Consulting Role - TradingView

Mangoceuticals to merge with Nuclea Energy to a... - Pluang

Mangoceuticals Inc (MGRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Mangoceuticals Inc (MGRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Mangoceuticals Inc (MGRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Mangoceuticals Inc (MGRX) Cash Flow - TradingKey

Mangoceuticals Inc (MGRX) Income Statement - TradingKey

MGRX|Mangoceuticals Inc|Price:0.542|Chg%:-0.001 - TradingKey

MGRX|Mangoceuticals Inc|Price:0.521|Chg%:-0.037 - TradingKey

Mangoceuticals (MGRX) Slips 6.58% as Stock Tests Critical Support LevelsDaily Profile - dars.gov.et

Mangoceuticals Inc (MGRX) Institutional Confidence - TradingKey

Mangoceuticals, Inc. Revenue Breakdown – NASDAQ:MGRX - TradingView

Mangoceuticals Inc (MGRX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Mangoceuticals stock doubles after Texas lawsuit - MSN

MGRX Q3 2025 Earnings: Net Loss Widens as Pre-Revenue Biotech Focuses on Clinical PipelineNet Profit Margin - po-news-eg.net

Price to sales forward of Mangoceuticals, Inc. – BOATS:MGRX - TradingView

Mangoceuticals (MGRX) Slips 2.46% as Stock Approaches Key Support at $0.34Zero Gamma Level - dars.gov.et

MGRX Q3 2025 Earnings: Wider Loss Reported as Stock Gains Despite Opaque Financial DisclosureBasic EPS Analysis - dars.gov.et

Price to earnings forward of Mangoceuticals, Inc. – NASDAQ:MGRX - TradingView

Mangoceuticals Inc Azioni (MGRX) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a MGRX